Seven Bridge Financial Group, LLC Supernus Pharmaceuticals, Inc. Call Options Transaction History
Seven Bridge Financial Group, LLC
- $465 Million
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SUPN
# of Institutions
255Shares Held
59.2MCall Options Held
47.9KPut Options Held
13.1K-
Black Rock Inc. New York, NY10.4MShares$320 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.14MShares$189 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.27MShares$162 Million1.83% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.87MShares$88.2 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.68MShares$82.4 Million0.08% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.64B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...